Journal list menu

Volume 284, Issue 1 p. 15-18
Full-length article
Free Access

Isolation of type I and type II GABAA-benzodiazepine receptors by immunoaffinity chromatography

J. Zezula

J. Zezula

Department of Biochemical Psychiatry, Psychiatrische Universitätsklinik, Vienna, Austria

Search for more papers by this author
W. Sieghart

Corresponding Author

W. Sieghart

Department of Biochemical Psychiatry, Psychiatrische Universitätsklinik, Vienna, Austria

Correspondence address: W. Sieghart, Dept. Biochem. Psychiatry, Psychiatrische Universitätsklinik Wien, Währinger Gürtel, 18-20, A-1090 Vienna, Austria. Fax: (43) (40) 400-3629Search for more papers by this author
First published: June 17, 1991
Citations: 37

Abstract

Anti-peptide α1 (1–9) and anti-peptide α3 (459–467) antibodies coupled to Affigel-10 were used for the isolation of GABAA receptors containing the α1-or α3-subunit, respectively. Both types of GABAA receptors exhibited a high affinity for [3H]flunitrazepam, and binding of [3H]flunitrazepam was stimulated in the presence of GABA. GABAA receptors eluted from the anti-peptide α1 (1–9) immunoaffinity column exhibited a high affinity and those from the anti-peptide α3 (459–467) columns a low affinity for the type I benzodiazepine receptor-selective ligand Cl 218872, indicating the enrichment of type I and type II GABAA-benzodiazepine receptors, respectively.